miramistin 300ml(10 OZ) antiseptic solution, used in densitry, surgery, gynecology, venereology, urology, antifungal

miramistin 0.01% 150ml (5 OZ) X 2 bottles 

Antiseptic Solution

This unique preparation MIRAMISTIN was developed within the Space Biotechnology Programme. One of the Programme's objectives was to find and develop a new preparation which would effectively fight most pathogenic microorganisms and act so that they would not develop resistance.As a result of multiple experiments, they managed to develop a preparation which when fighting microorganisms produces no adverse or by-effects on the human organism; moreover, it possesses a number of useful qualities: enhances local immunity, heals inflammatory processes, speeds up wound repair, etc. Through numerous clinical and scientific researches it has been proved that MIRAMISTIN is highly effective.

Pharmacodynamics:
Miramistin has a wide range of antimicrobial effects, including hospital strains resistant to antibiotics.
The drug has a pronounced bactericidal effect against gram-positive (Staphylococcus spp., Streptococcus spp., Streptococcus pneumoniae) and gram-negative (Pseudomonas aeruginosa, Escherichia coli, Klebsiella spp.), aerobic and anaerobic bacteria, defined as monocultures and microbial associations, including hospital strains with polyresistance to antibiotics .
It has an antifungal effect on ascomycetes of the genus Aspergillus and the genus Penicillium, yeast (Rhodotorula rubra, Torulopsis glabrata) and yeast-like fungi (Candida albicans, Candida tropicalis, Candida krusei, Pityrosporum orbiculare (Malassezia furfur), dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violacent, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis) in the form of monocultures and microbial associations, including fungal microflora with resistance to chemotherapeutic drugs.